ASCO: Microbiome Varies for Early-Onset, Late-Onset Colorectal Cancer
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, June 2, 2023 -- The microbiome (MB) of patients with colorectal cancer (CRC) varies between those diagnosed with early- or late-onset disease, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from June 2 to 6 in Chicago.
Benjamin Adam Weinberg, M.D., from the Georgetown University Lombardi Comprehensive Cancer Center in Washington, D.C., and colleagues compared the intratumoral MB in patients with CRC diagnosed before age 45 years (early-onset CRC [EOCRC]) and after age 65 years (late-onset CRC [LOCRC]) in a prospective/retrospective study. DNA was extracted from tumors, and the analysis was performed with 16S ribosomal gene sequencing. The frequency of Fusobacterium nucleatum (F. nuc) and other bacterial and fungal DNA was compared in tumors from 36 EOCRC and 27 LOCRC patients.
The researchers detected 917 unique bacterial and fungal species. F. nuc was detected in 30.6 and 29.6 percent of EOCRC and LOCRC patients, respectively. EOCRC more commonly had Cladosporium sp. (30.6 versus 11 percent), while LOCRC more often had Pseudomonas luteola (2.8 versus 22.2 percent), Ralstonia sp. (22.2 versus 48.1 percent), and Moraxella osloensis (19.4 versus 44.4 percent). LOCRC patients exclusively had Clostridium perfringens (11.1 percent), Escherichia coli (11.1 percent), Leptotrichia hofstadii (11.1 percent), Mycosphaerella sp. (11.1 percent), Neodevriesia modesta (11.1 percent), Penicillium sp. (11.1 percent), and Leptosphaeria sp. (11.1 percent). No significant difference was seen in median MB diversity for EOCRC versus LOCRC patients (43 versus 45 organisms per patient).
"Because we have tumor genetic data and diet questionnaire results from many of our patients, we hope to explore more relationships and other aspects of how the microbiome impacts colorectal cancer progression in the future," Weinberg said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Risk for Colorectal Cancer Is Low for Uncomplicated Diverticulitis
TUESDAY, May 7, 2024 -- The prevalence of colorectal cancer (CRC) is low for patients undergoing colonoscopy after an episode of uncomplicated diverticulitis, according to a study...
Extending Interval Between Colonoscopies Feasible After Negative Result
FRIDAY, May 3, 2024 -- For individuals without a family history of colorectal cancer (CRC), increasing the interval between colonoscopies for those with a first colonoscopy with...
Aspirin May Enhance Immunosurveillance Against Colorectal Cancer
MONDAY, April 22, 2024 -- Aspirin may promote an immune response against cancer, with fewer nodal metastases and higher infiltration of tumor-infiltrating lymphocytes among...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.